AzTrials
AzTrials

MyopiaPhase 2NCT06161311

Baseline Relative Peripheral Refraction in Myopia Control

A Phase 2 study testing DIMS lenses in people with Myopia, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Myopia has become a world concern and its prevalence has increased in recent decades. Myopic defocus has been applied for slowing down the axial elongation and myopia progression, which is mainly based on the theory of simultaneous competing defocus and peripheral optics. Read more about this study

Who is it for?
Ages 6 to 9 yearsHealthy volunteers can take part
Conditions the study is for
Myopia
What is being tested?
DIMS lenses
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteHong Kong
Study dates
1 Dec 2023to 3 Apr 2025
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 9 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age at enrolment: 6-9 years
  • Spherical equivalent refraction (SER): -0.75 to -5.00 Diopters (D)
  • Astigmatism: -1.50 D or less
  • Anisometropia: 1.50 D or less
  • Spectacle best-corrected monocular visual acuity (VA): 0.00 logMAR or better

Who cannot join

  • Ocular and systemic abnormalities might affect visual functions or refractive development
  • Prior use of any drugs or optical devices of myopia control treatment.

Trial locations and contacts

1 site in 1 country.

Tsz Wing Leung, PhD contact

27664268

jeffrey.TW.leung@polyu.edu.hk

Hong Kong1 site, 1 recruiting
  • Optometry Research Clinic

    Hong Kong, Hong Kong, nol

    Tsz Wing Leung, PhD, 27664268, jeffrey.TW.leung@polyu.edu.hk

    Recruiting

Other trials in Hong Kong

About this study

Official title: The Influence of Baseline Relative Peripheral Refraction in Myopia Control Using Myopic Defocus

Myopia has become a world concern and its prevalence has increased in recent decades. Myopic defocus has been applied for slowing down the axial elongation and myopia progression, which is mainly based on the theory of simultaneous competing defocus and peripheral optics. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses impose myopic defocus in the central or peripheral retina, with myopia progression being retarded by 50% to 60%. However, the optimal amount of myopic defocus has not yet been determined. Relative peripheral refraction (RPR) is used to indicate the difference between peripheral refraction and central refraction. Previous studies showed that retinal shape determined RPR, and baseline RPR may influence the myopia control efficacy using DIMS lenses on myopic children. It is still unclear if any other unknown factor influenced the final myopia control outcome in these young children with myopic RPR at baseline. Unlike our previous study8 that bias on hyperopic RPR children (myopic RPR, n = 27; hyperopic RPR, n = 52), this study is a case-control study with the same sample size for each RPR group. We will also include younger children who are more prone to have myopic RPR and develop high myopia. The results should provide new insight into the myopia control strategy in early-onset myopic children.

In the current study, we will investigate the influence of baseline RPR in myopia retardation using DIMS lenses among young myopic children.

Read more

This will ba a 1-year prospective clinical trial. Through G*Power (version 3.1.9.6) calculation, 80 healthy myopic subjects (40 myopic RPR vs 40 hyperopic RPR) aged 5-9 years should be needed. After screened by inclusion criteria, eligible participants will be assigned to wear DIMS lenses for 1 year (12 months, 8 hour per day, 7 days per week). This study includes 5 visits: Visit 1: baseline, Visit 2: lens dispensing, Visit 3: 2-week follow-up, Visit 4: 6-month follow-up, and Visit 5: 12-month follow-up. All eye examinations will be carried out in the Optometry Research Centre (A137), the School of Optometry, the Hong Kong Polytechnic University. The main data collection, including refractive error, axial length, related ocular parameters will be measured at baseline, 6-month and 1-year visits. At the lens dispensing and 2-week follow-up visits, vision acuity testing and computer scanning of posterior eyes will be measured. New DIMS lens will be replaced and upgraded if the equivalent sphere of refraction (SER) is changed or visual acuity change.

The following data will be statistically analyzed. The primary outcome data include the difference in change in SER with cycloplegia between the myopic and hyperopic RPR from the baseline over 12 months of treatment. Secondary outcomes data include the changes in axial length, peripheral refraction, relative peripheral refraction, the amplitude of accommodation, lag of accommodation, corneal curvature, phoria and stereoacuity.

Conditions
Myopia
Being tested
DIMS lenses
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DIMS lensesDevice

    Defocus incorporated multiple segments lenses, which use induce peripheral myopic defocus to control for myopia development in children

Study groups in NCT06161311
Study groupRoleWhat they receive
Myopic RPR groupActive comparatorPatients with myopic relative peripheral refraction
Receives: Device: DIMS lenses
Hyperopic RPR groupActive comparatorPatients with hyperopic relative peripheral refraction
Receives: Device: DIMS lenses

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cycloplegic refractive error

    Refractive error measured after instillation of cycloplegia

    Measured: Baseline; 2 weeks, 6 months and 12 months post-treatment

Secondary outcomes (5)
  1. Axial length

    Length of the eye

    Measured: Baseline; 2 weeks, 6 months and 12 months post-treatment

  2. Peripheral refraction

    Refractive errors at peripheral fields

    Measured: Baseline; 2 weeks, 6 months and 12 months post-treatment

  3. Amplitude and lag of accommodation

    Ability of the eyes to accommodate

    Measured: Baseline; 2 weeks, 6 months and 12 months post-treatment

  4. Corneal curvature

    Power of the cornea

    Measured: Baseline; 2 weeks, 6 months and 12 months post-treatment

  5. Phoria and stereoacuity

    Coordination of the two eyes

    Measured: Baseline; 2 weeks, 6 months and 12 months post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Dec 2023
  2. Study start1 Dec 2023
  3. Primary completion3 Apr 2025 (estimated)
  4. Study completion3 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06161311
Sponsor's protocol ID
HSEARS20221229003-01
Status last verified
Nov 2023
First submitted
30 Nov 2023
Last updated
2 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing DIMS lenses in people with Myopia, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tsz Wing Leung, PhD (27664268, jeffrey.TW.leung@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cycloplegic refractive error (time frame: Baseline; 2 weeks, 6 months and 12 months post-treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in